Methylnaltrexone PowerPoint PPT Presentation

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: Methylnaltrexone


1
(No Transcript)
2
(No Transcript)
3
Methylnaltrexone
4
GMK Malignant Melanoma- discontinued
Cancer Vaccines
PSMA - Joint Venture with Cytogen Phase 1
prostate cancer vaccine Preclin - antibody and
viral vector
5
HIV Entry Inhibitors
  • PRO 542
  • PII(single dose) (n12) - 60-80 reduction in
    viral load
  • PII(multi-dose) - ongoing
  • Preclinical PRO 140, Provax

6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
Cash ? Burn Rate Quarters Left (22.5 - 2.6) ?
7.4 2.6
Expect Upcoming Financing!
Write a Comment
User Comments (0)
About PowerShow.com